Complete Story
 

02/27/2013

KADCYLA (ado-trastuzumb emtansine)

First FDA approved antibody-drug conjugate (ADC) for HER2-positive metastatic breast cancer

 

TO VIEW PI and LEARN MORE CLICK HERE